These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 31969882)

  • 1. The Regulation of Host Intestinal Microbiota by Polyphenols in the Development and Prevention of Chronic Kidney Disease.
    Bao N; Chen F; Dai D
    Front Immunol; 2019; 10():2981. PubMed ID: 31969882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of intestinal barrier and microbiota in chronic kidney disease.
    Sabatino A; Regolisti G; Brusasco I; Cabassi A; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2015 Jun; 30(6):924-33. PubMed ID: 25190600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota in chronic kidney disease.
    Cigarran Guldris S; González Parra E; Cases Amenós A
    Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease and the gut microbiome.
    Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
    Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
    Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
    Pan W; Kang Y
    Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivities of Dietary Polyphenols and Their Effects on Intestinal Microbiota.
    Zhang X; Shao J; Cui Q; Ni W; Yang Y; Yan B
    Mini Rev Med Chem; 2023; 23(3):361-377. PubMed ID: 35959612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
    Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D
    Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uremic toxins and gut micro biome].
    Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND
    Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Polyphenol Compounds on Human Gastrointestinal Tract Microbiota.
    Wiciński M; Gębalski J; Mazurek E; Podhorecka M; Śniegocki M; Szychta P; Sawicka E; Malinowski B
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32013109
    [No Abstract]   [Full Text] [Related]  

  • 14. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
    Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
    Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of modulation of gut microbiota by dietary polyphenols.
    Dueñas M; Muñoz-González I; Cueva C; Jiménez-Girón A; Sánchez-Patán F; Santos-Buelga C; Moreno-Arribas MV; Bartolomé B
    Biomed Res Int; 2015; 2015():850902. PubMed ID: 25793210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Analysis of Intestinal Redox State with the Gut Microbiota Reveals the Positive Intervention of Tea Polyphenols on Hyperlipidemia in High Fat Diet Fed Mice.
    Ma H; Zhang B; Hu Y; Wang J; Liu J; Qin R; Lv S; Wang S
    J Agric Food Chem; 2019 Jul; 67(26):7325-7335. PubMed ID: 31184120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Modulation and Anti-Inflammatory Properties of Dietary Polyphenols in IBD: New and Consolidated Perspectives.
    Santino A; Scarano A; De Santis S; De Benedictis M; Giovinazzo G; Chieppa M
    Curr Pharm Des; 2017; 23(16):2344-2351. PubMed ID: 28176667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Neuroprotective Effect of Tea Polyphenols on the Regulation of Intestinal Flora.
    Zhang Z; Zhang Y; Li J; Fu C; Zhang X
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between Tea Polyphenols and Intestinal Microbiota in Host Metabolic Diseases from the Perspective of the Gut-Brain Axis.
    Yan R; Ho CT; Zhang X
    Mol Nutr Food Res; 2020 Jul; 64(14):e2000187. PubMed ID: 32506625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.